fda and compound semaglutide Compounded for Weight Loss If it's not FDA-approved, it's
Description
By that summer, I had lost 30 pounds, but the GLP-1 was not working in the way Id hoped
The result is the prolonged fullness patients describe as feeling "the meal in their chest" hours later, often accompanied by reflux as stomach contents back up against a relaxed lower oesophageal sphincter
[DOI] [PMC free article] [PubMed] [Google Scholar] 151.Liskiewicz A, Khalil A, Liskiewicz D, et al
.png)
You should remain on your GLP-1 therapy until your weight loss goal is met

On February 20, 2026, the FDA issued warning letter #721455 to MEDVi, LLC
Marquez-Meneses JD, Olaya-Bonilla SA, Barrera-Carreo S, et al
